Innovation1 Biotech Inc. (IVBT)

USD 0.0

(0.0%)

Operating Income Summary of Innovation1 Biotech Inc.

Innovation1 Biotech Inc.'s latest annual operating income in 2023 was -1.36 Million USD , up 96.91% from previous year.
Innovation1 Biotech Inc.'s latest quarterly operating income in 2023 FY was -1.26 Million USD , up 96.91% from previous quarter.
Innovation1 Biotech Inc. reported an annual operating income of -41.02 Million USD in 2022, down -17067.97% from previous year.
Innovation1 Biotech Inc. reported an annual operating income of -238.99 Thousand USD in 2021, down -10.2% from previous year.
Innovation1 Biotech Inc. reported a quarterly operating income of -203.61 Thousand USD for 2023 Q2, up 72.35% from previous quarter.
Innovation1 Biotech Inc. reported a quarterly operating income of -203.61 Thousand USD for 2023 Q3, down 0.0% from previous quarter.

Annual Operating Income Chart of Innovation1 Biotech Inc. (2023 - 2015)

Historical Annual Operating Income of Innovation1 Biotech Inc. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-1.36 Million USD	96.91%
2022	-41.02 Million USD	-17067.97%
2021	-238.99 Thousand USD	-10.2%
2020	-216.87 Thousand USD	67.53%
2019	-667.98 Thousand USD	-53.17%
2018	-436.11 Thousand USD	-1116.51%
2017	-35.85 Thousand USD	-2.41%
2016	-35 Thousand USD	-141.05%
2015	-14.52 Thousand USD	0.0%

Year	Operating Income	Operating Income Growth
2023 FY	-1.26 Million USD	96.91%
2023 Q2	-203.61 Thousand USD	72.35%
2023 Q3	-203.61 Thousand USD	0.0%
2023 Q4	201.33 Thousand USD	198.88%
2023 Q1	-736.28 Thousand USD	-17.09%
2022 Q1	-361.07 Thousand USD	-360.3%
2022 FY	-41.02 Million USD	-17067.97%
2022 Q4	-628.82 Thousand USD	60.58%
2022 Q3	-1.59 Million USD	10.49%
2022 Q2	-1.78 Million USD	-393.63%
2021 FY	-238.99 Thousand USD	-10.2%
2021 Q3	-47.09 Thousand USD	16.31%
2021 Q2	-56.27 Thousand USD	1.58%
2021 Q1	-57.17 Thousand USD	-138.64%
2021 Q4	-78.44 Thousand USD	-66.55%
2020 Q3	-199.57 Thousand USD	-84.5%
2020 Q2	-108.17 Thousand USD	-89.43%
2020 Q4	147.96 Thousand USD	174.14%
2020 Q1	-57.1 Thousand USD	68.07%
2020 FY	-216.87 Thousand USD	67.53%
2019 Q3	-143.25 Thousand USD	7.15%
2019 Q2	-154.28 Thousand USD	19.47%
2019 Q1	-191.59 Thousand USD	29.78%
2019 FY	-667.98 Thousand USD	-53.17%
2019 Q4	-178.84 Thousand USD	-24.84%
2018 Q4	-272.83 Thousand USD	-1347.63%
2018 Q2	-121.77 Thousand USD	-437.35%
2018 Q1	-22.66 Thousand USD	-49.43%
2018 FY	-436.11 Thousand USD	-1116.51%
2018 Q3	-18.84 Thousand USD	84.52%
2017 Q3	-3975.00 USD	15.44%
2017 Q4	-15.16 Thousand USD	-281.53%
2017 FY	-35.85 Thousand USD	-2.41%
2017 Q1	-12 Thousand USD	-71.54%
2017 Q2	-4701.00 USD	60.85%
2016 Q1	-7844.00 USD	-169.37%
2016 Q4	-7000.00 USD	53.33%
2016 Q3	-15 Thousand USD	-190.47%
2016 Q2	-5164.00 USD	34.17%
2016 FY	-35 Thousand USD	-141.05%
2015 FY	-14.52 Thousand USD	0.0%
2015 Q2	-2034.00 USD	0.0%
2015 Q3	-3820.00 USD	-87.81%
2015 Q4	-2912.00 USD	23.77%

Peer Operating Income Comparison of Innovation1 Biotech Inc.

Name	Operating Income	Operating Income Difference
America Great Health	-492.64 Thousand USD	-177.561%
Gene Biotherapeutics, Inc.	- USD	Infinity%
Evolutionary Genomics, Inc.	-2.01 Million USD	32.116%
Point of Care Nano-Technology, Inc.	-78.01 Thousand USD	-1652.677%
Vicapsys Life Sciences, Inc.	-1.04 Million USD	-30.603%